13351-68-3 Usage
Chemical structure
Contains a pentitol derivative, a pyrazolo[4,3-d]pyrimidine ring, and a methylamino group
Application
Mainly used in pharmaceutical research
Purpose
As a potential drug candidate for the treatment of various medical conditions
Unique properties
Facilitates study of potential therapeutic effects
Interaction
With specific biological targets
Activity
Tested in cellular and animal models
Importance
Contributes to drug discovery and development
Check Digit Verification of cas no
The CAS Registry Mumber 13351-68-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,3,5 and 1 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 13351-68:
(7*1)+(6*3)+(5*3)+(4*5)+(3*1)+(2*6)+(1*8)=83
83 % 10 = 3
So 13351-68-3 is a valid CAS Registry Number.
13351-68-3Relevant academic research and scientific papers
Pyrazolopyrimidine Nucleosides. 9. Studies of the Isomeric N-Methylformycins
Lewis, Arthur F.,Townsend, Leroy B.
, p. 2817 - 2822 (2007/10/02)
The syntheses of 4-methylformycin (7) and 6-methylformycin (8) are described.Structural assignements if 7 and 8 were based on UV, 1H NMR, and 13C NMR data.N-7-Methylformycin (9) was resynthesized by an alternative route and comparisons of the physicochemical properties of all five of the mono-N-methylformycins are presented. 6-Methylformycin (8) was found to be unstable in aqueous solution yielding three products, formycin B (2), N-7-methylformycin (9), and 6-methylformycin B (10). 6-Methylformycin B (10), 4-methylformycin B (11), and 1-methylformycin B (12) were prepared by a reaction of nitrosyl chloride with 8, 7, and 1-methylformycin (3), respectively.
